Email this article 
INSIDENSI DAN FAKTOR RISIKO CORONARY SLOW FLOW: SYSTEMATIC REVIEW
Abstract
Studi epidemiologis tentang kejadian CSF penting untuk lebih memahami faktor risiko dan menentukan riwayat alami kondisi tersebut. Oleh karena itu, systematic review ini dibuat untuk membahas insiden terjadinya CSF, serta mengetahui berbagai prediktor yang terkait dengan terjadinya CSF. Tinjauan sistematis ini dianalisis dengan menggunakan metode PRISMA-P 2015. Berdasarkan hasil pencarian, terdapat 10 artikel relevan yang memenuhi kriteria untuk dianalisis. Hasil analisis didapatkan hasil kejadian CSF 34% dan 34,2% pada artikel berdesain case control, sedangkan 1 artikel berdesain cross sectional yang didapatkan 1,43% kejadian CSF. Faktor risiko terkait atau prediktor terkait dengan terjadinya fenomena coronary slow flow (CSF) yaitu, BMI tinggi, lingkar pinggang tinggi, hipertensi, diabetes melitus, dislipidemia, merokok dan jenis kelamin laki-laki, usia >50 tahun, tingkat SII (systemic immune inflammation), kadar urotensin II, dan faktor psikologis. Kesimpulan didapatkan Angka kejadian coronary slow flow (CSF) cukup tinggi. Berbagai faktor risiko atau prediktor fenomena CSF terdapat faktor yang bisa diubah maupun yang tidak bisa diubah.
Keywords
Full Text:
PDFReferences
Chalikias G, Tziakas D. Slow Coronary Flow: Pathophysiology, Clinical Implications, and Therapeutic Management. Angiology. 2021;72(9):808– 18.
Tanta Y, Ghanie A, Indrajaya T, Sukandi E, Saleh I, Maritska Z. The Application of Coronary Contrast Emptying Time in Diagnosing Coronary Slow Flow Phenomenon: A Serial Case Report. Acta Med Indones. 2022;54(4):621–5.
Aparicio A, Cuevas J, Morís C. Slow Coronary Blood Flow : Pathogenesis and Clinical Implications. Eur Cardiol Rev. 2022;
Rouzbahani M, Farajolahi S, Montazeri N, Janjani P, Salehi N, Rai A, et al. Prevalence and predictors of slow coronary flow phenomenon in Kermanshah province. J Cardiovasc Thorac Res [Internet]. 2021;13(1):37–42. Available from: https://doi.org/10.34172/jcvtr.2021.03
Ghanie A, Partan RU, Indrajaya T, Ali Z, Saleh MI, Hidayat R. The effect of angiotensin-converting enzyme gene polymorphisms in the coronary slow flow phenomenon at south sumatra, indonesia population. Open Access Maced J Med Sci. 2020;8(A):225–30.
Zhu Q, Wang S, Huang X, Zhao C, Wang Y, Li X, et al. Understanding the Pathogenesis of Coronary Slow Flow: Recent Advances. Trends Cardiovasc Med [Internet]. 2022;(xxxx). Available from: https://doi.org/10.1016/j.tcm.2022.12.001
?atiro?lu Ö, Durako?lugil ME, Çetin M, Çiçek Y, Erdo?an T, Duman H. The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow. Interv Med Appl Sci. 2016;8(4):158–63.
Arbel Y, Rind E, Banai S, Halkin A, Berliner S, Herz I, et al. Prevalence and predictors of slow flow in angiographically normal coronary arteries. Clin Hemorheol Microcirc. 2012;52(1):5–14.
Metwally YG, Sedrak HK, Shaltout IF. Coronary slow flow in patients with impaired glucose tolerance and insulin resistance. Egypt J Intern Med. 2020;32(1):1–5.
Mukhopadhyay S, Kumar M, Yusuf J, Gupta VK, Tyagi S. Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study. Indian Heart J [Internet]. 2018;70(3):405–9. Available from: http://dx.doi.org/10.1016/j.ihj.2017.09.00 1
Mareai RM, Mohammed AQ, Zhang H, Liu L, Zhang W, Mohammed AA, et al. Prognostic implication of coronary slow flow assessed by cTFC in patients with myocardial infarction with Non- obstructive coronary arteries. Eur J Intern Med [Internet]. 2022;108(December 2022):74–80. Available from: https://doi.org/10.1016/j.ejim.2022.11.026
Afsin A, Kaya H, Suner A, Uzel KE, Bursa N, Hosoglu Y, et al. Plasma atherogenic indices are independent predictors of slow coronary flow. BMC Cardiovasc Disord [Internet]. 2021;21(1):1–10. Available from: https://doi.org/10.1186/s12872-021- 02432-5
Zhu X, Shen H, Gao F, Wu S, Ma Q, Jia S, et al. Clinical Profile and Outcome in Patients with Coronary Slow Flow Phenomenon. Cardiol Res Pract. 2019;2019.
Dai X tong, Kong T zhong, Zhang X jiao, Luan B, Wang Y, Hou A jie. Relationship between increased systemic immune- inflammation index and coronary slow flow phenomenon. BMC Cardiovasc Disord [Internet]. 2022;22(1):1–11. Available from:
https://doi.org/10.1186/s12872-022- 02798-0
Elamragy AA, Abdelhalim AA, Arafa ME, Baghdady YM. Anxiety and depression relationship with coronary slow flow. PLoS One [Internet]. 2019;14(9):1–11. Available from:
http://dx.doi.org/10.1371/journal.pone.022 1918
Gökçe M, Kaplan S, Tekelioglu Y, Erdo?an T, Kücükosmano?lu M. Platelet function disorder in patients with coronary slow flow. Clin Cardiol. 2005;28(3):145– 8.
Honing MLH, Morrison PJ, Banga JD, Stroes ESG, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev. 1998;14(3):241–9.
Elsherbiny IA, Shoukry A, Tahlawi MAE. Mean platelet volume and its relation to insulin resistance in non-diabetic patients with slow coronary flow. J Cardiol [Internet]. 2012;59(2):176–81. Available from: http://dx.doi.org/10.1016/j.jjcc.2011.11.00 9
Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol. 2004;43(10):1731–7.
Zhu Q, Wang S, Huang X, Zhao C, Wang Y, Li X, et al. Understanding the pathogenesis of coronary slow flow: Recent advances. Trends Cardiovasc Med [Internet]. 2022;(xxxx). Available from: https://doi.org/10.1016/j.tcm.2022.12
DOI: https://doi.org/10.32539/JKK.V10I2.21087
Refbacks
- There are currently no refbacks.
E-ISSN (Online) : 2614-0411
Jl. Dr. Moehammad Ali Kompleks RSMH Palembang 30126, Indonesia
Telp. 0711-352342, Fax.: 0711-373438
email: jurnalfkunsri@gmail.com
Jurnal Kedokteran dan Kesehatan : Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya by https://ejournal.unsri.ac.id/index.php/jkk is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.